Please login to the form below

Not currently logged in
Email:
Password:

Report reveals best-in-class, cross-functional marketing teams

A new Best Practices report reveals how an effective cross-functional team can lay the groundwork for a new pharmaceutical product's success in the marketplace, both initially and long-term.

A new Best Practices report reveals how an effective cross-functional team can lay the groundwork for a new pharmaceutical product's success in the marketplace, both initially and long-term.

Pharma companies say that the various activities of a cross-functional team are responsible for half of a drug's success, with the other half embedded in the biological attributes of the compound, according to Best Practices, a US-based research and consultancy company.

The report, entitled "Managing Cross-Functional Teams for Pharmaceutical Product Commercialisation Excellence", reveals the best-in-class practices implemented by leading companies use to establish effective cross-functional teams, such as empowering teams to make key decisions and make teams follow standardised processes.

In the study, companies found benefit in moving various marketing activities up in the development schedule to help understand market needs earlier in the process. A sample of study participants found that teams averaged 0.5 marketing FTEs at pre-clinical, 1.8 marketing FTEs at phase II and 5.6 marketing FTEs at launch.

Study participants included Amgen, Novartis, GlaxoSmithKline, Merck and Johnson & Johnson. Findings were based on a two-pronged research approach:
benchmark surveys were performed on more than 49 companies and interviews with directors and managers involved with managing teams across units, functions or countries.


28th September 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics